There are 383 resources available
174P - Pulmonary tuft cell-like cancers across different histotypes share molecular features with potentially druggable vulnerabilities
Presenter: Yosuke Yamada
Session: Poster Display session
175P - Mutations and clinical significance of calcium voltage-gated channel subunit alpha 1E (CACNA1E) in non-small cell lung cancer
Presenter: guizhen Wang
Session: Poster Display session
176P - Phase transition early-invasive lung cancer and blood cell circuit
Presenter: Oleg Kshivets
Session: Poster Display session
177P - Feasibility and usefulness of evaluation of immune status of lung cancer patients by EBUS/TBNA cells analysis
Presenter: Joanna Domagala-Kulawik
Session: Poster Display session
60P - Machine learning based on blood biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy
Presenter: Jian-Guo Zhou
Session: Poster Display session
61P - Updated efficacy and ctDNA analysis of patients with TRK fusion lung cancer treated with larotrectinib
Presenter: Victor Moreno Garcia
Session: Poster Display session
62P - Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small cell lung cancer patients
Presenter: Shinkichi Takamori
Session: Poster Display session
63P - Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): Neutrophil to lymphocyte ratio (NLR) and the risk for toxicity recurrence
Presenter: Giulia Pretelli
Session: Poster Display session
64P - Clinical benefit of platinum doublet therapy for elderly patients with advanced non-small cell lung cancer: A prospective multicenter study of the national hospital organization in Japan
Presenter: Mototsugu Shimokawa
Session: Poster Display session
65P - Blood cytokine changes in patients with advanced NSCLC receiving immunotherapy
Presenter: Hannah Schindler
Session: Poster Display session